Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604
NASA has not yet announced the release of any additional topics
The low price point of research chemical GHK-Cu is not an advantage when the risks include systemic infection, immune reactions, and unknown contamination
Our study on the subject constitutes not only the time weve spent reading the scientific literature but also our relationships with licensed medical providers who prescribe peptides and with people who use them
UPP1 facilitates the conversion of 5-FU into its active compounds, thereby enhancing its inhibitory effect on thymidylate synthase
AptCTLA-4 blocks CTLA-4 from binding with its ligands, B7-1 (CD80) and B7-2 (CD86)
